The CRO of ZM, Ryan Azus, has already sold around 6,250 shares of the stocks of the company in a 7th April research report. The average price of the shares was $323.90, with a total transaction value of around $2,024,375. The CRO currently owns around 47,667 shares of the stock of the company which has a total valuation of over $15 million. The transaction has been documented on the official SEC website of SEC.
The Quarterly Estimates Of ZM
The stocks of ZM traded on Friday at $8.63. The moving average price of the company over a period of 50 days is $348.29, with the moving average price of the company over 200 days is $409.19. The year low of the company is $125.60, while the year high of the company is $588.84. The market cap of the firm is $94.77 billion, with a 424.72 PE ratio.
ZM did put up their next quarterly results on the 28th of February. The EPS reported by the company for the shares was $1.22, which beat out the consensus estimate of around $0.79. The revenue for the company was $882.49 million for that quarter, which was more than the consensus estimate of about $810.97 million. The return on equity for the company was 27.93%, with a 17.10% net margin.
There have been quite a few research equities that have commented on the stocks of the company. Zacks has already reduced the price rating of the company from buy to hold with a price target of $354 set on the company in an 8th March research report. Deutsche Bank has also put up a rating of hold, with a price target of $360 in a 1st April research report. Rosenblatt Securities has increased the price target of the company from $350 to $400 with a rating of neutral in an 8th March research report.